Expertise in

conditions

Djillali Annane

Paris, FR

Clinical Trials:Currently Recruiting for 1 Trial

Expertise in

conditions

Paris, FR

Overview

Djillali Annane practices practicing medicine in Paris, France.

Mr. Annane is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Sepsis, COVID-19, Myasthenia Gravis, Hepato-Pancreato-Biliary Surgery, and Thrombectomy.

He is actively involved in clinical research, co-authoring 401 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Paris, France

Other Locations

Versailles, France

Hendaye, France

Garches, France

Montigny-sur-loing, France

Villejuif, France

Creteil, France

Boulogne-billancourt, 92100, France

Saint-aubin-les-forges, France

Nimes, France

Besancon, France

104. Boulevard Raymond Poincaré, Garches, 92380, Irles, France

Raymond, 92380, France

Saint-quentin-le-verger, France

INSERM U1173, University Of Versailles St Quentin, INSERM U1028, CNRS UMR5292, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock

Enrollment Status: Recruiting

Publish Date: August 05, 2025

Intervention Type: Drug

Study Drug: Levosimendan

Study Phase: Phase 3

Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial

Enrollment Status: Terminated

Publish Date: February 09, 2026

Intervention Type: Procedure

Study Phase: Phase 3

Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia

Enrollment Status: Completed

Publish Date: December 22, 2025

Intervention Type: Drug

Study Drug: Hydrocortisone

Study Phase: Phase 3

Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock

Enrollment Status: Unknown

Publish Date: August 31, 2023

Intervention Type: Drug

Study Drug: Esmolol

Study Phase: Phase 2

Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.

Enrollment Status: Terminated

Publish Date: February 06, 2023

Intervention Type: Drug

Study Phase: Phase 2

Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections

Enrollment Status: Completed

Publish Date: August 19, 2021

Intervention Type: Drug

Study Drug: Human Immunoglobulin

Study Phase: Phase 3

Cough Determinants in Mechanically Ventilated Patients: a Physiological Study

Enrollment Status: Completed

Publish Date: April 22, 2019

Intervention Type: Other

Study Phase: Not Applicable

View 6 Less Clinical Trials

400 Total Publications

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Journal: medRxiv : the preprint server for health sciences

Published: April 10, 2026

View All 400 Publications

Frequently Asked Questions about Djillali Annane

Is Djillali Annane a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Djillali Annane is classified as an Elite expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Djillali Annane participate in research or clinical trials?

Yes. Djillali Annane has published 400 articles and abstracts on conditions like Sepsis. You can view a list of Djillali Annane's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Annane's expertise for a condition

ConditionClose